CIPO Patents = 1

EPO Patents = 1

Forward Citations = 19

Loading Chart...

10 inventors (with patents filed for the assignee):

Kristen Marie Lorentz (4 out of 4 patents)

David Scott Wilson (4 out of 11 patents)

Jeffrey Alan Hubbell (4 out of 135 patents)

4. Shuning Gai (3 out of 3 patents)

5. Stéphane Kontos (3 out of 6 patents)

6. Stephan Kontos (1 out of 12 patents)

7. Kristen Marie Lorentz (1 out of 1 patent)

8. Kym Brünggel (1 out of 1 patent)

9. Jeffrey A Hubbell (1 out of 3 patents)

10. David Scott Wilson (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 12383617 - Compositions and methods concerning immune tolerance (2025-08-12),

2. 11666638 - Glycotargeting therapeutics (2023-06-06),

3. 11654188 - Glycotargeting therapeutics (2023-05-23),

4. 11253579 - Compositions and methods for inducing immune tolerance (2022-02-22),

5. 10821157 - Glycotargeting therapeutics (2020-11-03),

Anokion SA is a biotechnology company focused on developing novel therapies for autoimmune diseases. The company's proprietary platform leverages the natural tolerance-inducing pathways of the immune system to create antigen-specific immune tolerance therapies. Anokion's innovative approach has the potential to revolutionize the treatment of autoimmune diseases and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

5 Patents

#9 in Ecublens

#1,653 in Switzerland

Ecublens, Switzerland

Anokion Sa

Forward Citations = 19

10 inventors:

Kristen Marie Lorentz (4 out of 4 patents)

David Scott Wilson (4 out of 11 patents)

Jeffrey Alan Hubbell (4 out of 135 patents)

4. Shuning Gai (3 out of 3 patents)

5. Stéphane Kontos (3 out of 6 patents)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com